S1: E2 The State of Clinical Trials in the UK

Om avsnittet

On this episode of ACRO’s Good Clinical Podcast, host Sophia McLeod is joined by Lord James O’Shaughnessy (Co-Founder & Senior Partner, Newmarket Strategy), Alistair MacDonald (Operating Partner, GHO Capital Partners), and Leona Fitzgerald (Executive Director, Regulatory Affairs, PPD, part of Thermo Fisher Scientific). Building off Lord O’Shaughnessy’s Report on Clinical Trials in the UK, listen to their discussion about approval timelines, implementation, governmental response, and where we must go from here.

Om avsnittet

Fler avsnitt

S5: E2 The Future of Early-Stage Trials: Speed, Safety, and Innovation

S5: E1 The Journey of RBQM & AI for Trial Monitoring: Where We Are

S4: E8 Moving from Awareness to Execution in Trial Representation

S4: E7 Advancing Sustainability Through Smarter Clinical Trial Design

S4: E6 Collaborating to Drive Global Progress in Clinical Research

S4: E5 Advancing Rare Disease Research Through AI Innovation and Patient Trust

S4: E4 Improving Site Feasibility Through Better Data Collaboration and Timing

S4: E3 Evolving Patient Engagement from Transactional to Transformational

S4: E2 How Small Grants Drive Big Changes Through Site-Led Innovation

S4: E1 Building a Global AI Framework for Clinical Trials